Search

everythinglearnresearchcommunity

for

Search:↓

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

CaBP1 and CaBP2 are important for continuous hearing by preventing inactivation of calcium currents in ear cells, with CaBP2 also able to restore hearing when reintroduced.

Targeting ornithine decarboxylase can help prevent skin cancer.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

A new patch can deliver stable antibodies over time for potential HIV treatment.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Genetic variants in specific genes cause central centrifugal cicatricial alopecia.

Hair loss in male pattern baldness involves muscle degeneration and increased scalp fat.

Dutasteride may help reduce brain plaque linked to Alzheimer's by affecting cell energy structures and waste removal.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

PRP preparation partially activates platelets, causing varied growth factor release.

The androgen receptor gene doesn't affect women with recurrent spontaneous abortions, but having a mutant genotype might protect against it.

Researchers found a new mutation causing total hair loss from birth.

Ectodysplasin-A1 is crucial for developing hair, teeth, and glands.

The OVOL1-OVOL2 axis is important for hair follicle differentiation and can help diagnose certain hair-related tumors.

Dutasteride showed some prevention of prostate issues but also had limitations, especially with high-grade tumors.

A mutation in the SREBF1 gene causes both hereditary mucoepithelial dysplasia and IFAP syndrome, which are related conditions.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

A gene called HDAC9 might be a new factor in male-pattern baldness.

Sphingosine 1-phosphate affects inflammation and gene expression in different aorta cells.

Arg1+ macrophages may play a role in causing alopecia areata.

Valproic acid may help hair grow and could be a safe treatment for hair loss.

Androgenetic alopecia is linked to a higher risk of varicose veins, especially in men, but not to major vascular diseases.

Urinary PSA could be an early marker for enlarged prostate.

Certain gene variations in PITX2 are linked to a higher risk of male pattern baldness in Indians.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

A gene in Arabidopsis thaliana, AtPRPL1, affects root hair length but not cell wall composition.

DHT enhances androgen receptor activity more than testosterone, and MAGE-11 influences this activity through specific interactions.